GSK: GSK plc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-13 | Fell below 5% | Dodge & Cox | 4.30% | SEC |
Institutional ownership (Q2 2026)
1,048 institutions reported holding $16.85B of GSK plc on Form 13F (1,037 the quarter before). 92 opened a new position and 81 sold out. Shares held by institutions: -7%.
| Largest holders | Shares | Value |
|---|---|---|
| FMR LLC | 64,961,641 | $3.41B |
| Dodge & Cox | 48,197,514 | $2.53B |
| Fisher Asset Management, LLC | 35,722,792 | $1.87B |
| PRIMECAP MANAGEMENT CO/CA/ | 25,182,068 | $1.32B |
| WELLINGTON MANAGEMENT GROUP LLP | 11,396,249 | $597.39M |
| MORGAN STANLEY | 7,657,562 | $401.41M |
| ROYAL BANK OF CANADA | 7,588,928 | $397.81M |
| GOLDMAN SACHS GROUP INC | 6,371,442 | $333.99M |
| STATE STREET CORP | 5,959,115 | $315.14M |
| Mondrian Investment Partners LTD | 4,910,830 | $257.43M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.